(254 days)
No
The document describes image processing and analysis techniques like segmentation, 3D reconstruction, and distance mapping algorithms, but does not mention AI, ML, or deep learning. The analysis is based on semi-automatic contour detection and established algorithms, not learned models.
No.
The device is described as a software product intended to aid in reading, co-registering, and interpreting cardiovascular X-Ray images to support diagnoses and for assistance during intervention. It provides tools for measurement and analysis but does not directly treat or prevent a disease.
Yes
Explanation: The "Intended Use / Indications for Use" section explicitly states that the product is "intended to be used...to support diagnoses." Additionally, it mentions features like "Quantify stenosis," "Quantify the motion of the left and right ventricular wall," and "Perform density measurements," all of which are diagnostic tasks.
Yes
The device is explicitly described as a "stand-alone modular software product" intended to run on a standard PC with a Windows operating system. While it processes data from medical imaging hardware (X-ray, IVUS, OCT), the device itself is solely the software application.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for the diagnosis, treatment, or prevention of disease.
- CAAS Workstation's Function: The CAAS Workstation is a software product that analyzes medical images (X-Ray angiographic, IVUS, and OCT) taken from within the body. It does not analyze specimens taken from the body.
- Intended Use: The intended use clearly states it's for "reading, co-registering and interpreting cardiovascular X-Ray images" and "co-registration of angiographic X-Ray images with IVUS and OCT images." This is image analysis, not in vitro testing of biological samples.
Therefore, while it is a medical device used to support diagnosis and intervention, it does not fit the definition of an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
CAAS Workstation features segmentation of cardiovascular structures, 3D reconstruction of vessel segments and catheter path based on multiple angiographic images, measurement and reporting tools to facilitate the following use:
- · Calculate the dimensions of cardiovascular structures;
- · Quantify stenosis in coronary and peripheral vessels;
- · Quantify the motion of the left and right ventricular wall;
- · Perform density measurements;
- · Determine C-arm position for optimal imaging of cardiovascular structures;
- · Enhance stent visualization and measure stent dimensions;
- · Co-registration of angiographic X-Ray images with IVUS and OCT images.
CAAS Workstation is intended to be used by or under supervision of a cardiologist or radiologist. When the results provided by CAAS Workstation are used in a clinical setting to support diagnoses and for assistance during intervention of cardiovascular conditions, the results are explicitly not to be regarded as the sole, irrefutable basis for clinical decision making.
Product codes
IZI, LLZ
Device Description
CAAS Workstation is designed as a stand-alone modular software product for viewing and quantification of X-ray angiographic images intended to run on a PC with a Windows operating system. CAAS Workstation contains the analysis modules QCA, QCA3D, QVA, LVA, RVA and StentEnhancer of the previously cleared predicate device CAAS Workstation (K133993) for calculating dimensions of coronary and peripheral vessels and the left and right ventricles, quantification of stenosis, performing density measurements, determination of optimal C-arm position for imaging of vessel segments and functionality to enhance the visualization of a stent and to measure stent dimension. Semi-automatic contour detection forms the basis for the analyses.
Functionality to co-register X-ray angiographic images and intravascular imaging techniques (such as intravascular ultrasound and optical coherence tomography) is added by means of the analysis module IV-LINQ. With co-registration a common frame of intravascular imaging techniques with X-ray angiographic images is provided using a three-dimensional model. This functionality is based on the Volcano Angio-IVUS Mapping system (K060483).
In the IV LINQ workflow the user has to select two angiographic X-ray images in DICOM format. The user indicates a catheter path starting at the imaging tip. This path can be optimized manually by adding, deleting or moving control point on the drawn path. After the catheter path is drawn in both angiographic X-ray images, a 3D reconstruction of the catheter path is calculated.
The user then has to select one IVUS or OCT dataset in DICOM format or the data is streamed from the intravascular imaging console with a DVI streamer. The IVUS or OCT pullback must be acquired using a motorized pullback device. After the 3D catheter path from X-ray angiographic images is calculated and the IVUS or OCT pullback is loaded, IV-LINQ co-registers each IVUS or OCT frame with a position on the 3D catheter path using a distance mapping algorithm. On intravascular images diameter and area measurements can be performed.
The quantitative results of CAAS Workstation support diagnosis and intervention of cardiovascular conditions. The analysis results are available on screen, and can be exported in various electronic formats. The functionality is independent of the type of vendor acquisition equipment.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
X-Ray Angiography, IVUS, OCT
Anatomical Site
Cardiovascular structures, coronary and peripheral vessels, left and right ventricular wall
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Cardiologist or radiologist / clinical setting
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
System requirements – derived from the intended use and indications for use – as well as risk control measures are verified by system testing. System testing showed that the system requirements were implemented correctly. For each analysis workflow a validation approach is created and the proper functioning of the algorithms is validated. For analysis workflows already implemented in earlier versions of CAAS Workstation regression testing is performed to verify equivalence in numerical results. The validation of the distance mapping algorithm used in IV LINQ demonstrated that the length on which co-registration is based, meets the accuracy and reproducibility requirements. Usability testing is performed to validate the IV-LINQ workflow of CAAS Workstation and demonstrated that the user is able to use IV LINQ for the purpose it was developed for.
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
System testing showed that the system requirements were implemented correctly. The validation of the distance mapping algorithm used in IV LINQ demonstrated that the length on which co-registration is based, meets the accuracy and reproducibility requirements. Usability testing demonstrated that the user is able to use IV LINQ for the purpose it was developed for. The test results demonstrate safety and effectiveness of CAAS Workstation in relation to its intended use and that CAAS Workstation is considered as safe and effective as the predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1600 Angiographic x-ray system.
(a)
Identification. An angiographic x-ray system is a device intended for radiologic visualization of the heart, blood vessels, or lymphatic system during or after injection of a contrast medium. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized depiction of an eagle with three human profiles incorporated into its design. The profiles are arranged in a way that they form the body and wings of the eagle. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the eagle symbol.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
March 11, 2016
Pie Medical Imaging B.V. % Ms. Florie Daniels Regulatory Affairs Coordinator Philipsweg 1 Maastricht, Limburg 6227 AJ THE NETHERLANDS
Re: K151780
Trade/Device Name: CAAS Workstation Regulation Number: 21 CFR 892.1600 Regulation Name: Angiographic x-ray system Regulatory Class: II Product Code: IZI, LLZ Dated: February 1, 2016 Received: February 8, 2016
Dear Ms. Daniels:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
1
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Michael D.'Hara
Robert Ochs, Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
For
Enclosure
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known) K151780
Device Name CAAS Workstation
Indications for Use (Describe)
CAAS Workstation features segmentation of cardiovascular structures, 3D reconstruction of vessel segments and catheter path based on multiple angiographic images, measurement and reporting tools to facilitate the following use:
- · Calculate the dimensions of cardiovascular structures;
- · Quantify stenosis in coronary and peripheral vessels;
- · Quantify the motion of the left and right ventricular wall;
- · Perform density measurements;
- · Determine C-arm position for optimal imaging of cardiovascular structures;
- · Enhance stent visualization and measure stent dimensions;
- · Co-registration of angiographic X-Ray images with IVUS and OCT images.
CAAS Workstation is intended to be used by or under supervision of a cardiologist or radiologist. When the results provided by CAAS Workstation are used in a clinical setting to support diagnoses and for assistance during intervention of cardiovascular conditions, the results are explicitly not to be regarded as the sole, irrefutable basis for clinical decision making.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
Form Approved: OMB No. 0910-0120
Expiration Date: January 31, 2017
See PRA Statement below.
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
| 510(k) Summary | CAAS Workstation | [GEN1934]v3.0 |
|---|---|---|
| Submitter/Owner Name | Pie Medical Imaging BV | |
| Address | Philipsweg 1, 6227 AJ Maastricht, The Netherlands | |
| Phone Number | +31 43 32 81 328 | |
| Fax Number | +31 43 32 81 329 | |
| Contact Person: | Florie Daniels, Regulatory Affairs Coordinator | |
| Email Address | Florie.Daniels@pie.nl | |
| Preparation Date | 26-Jun-2015 | |
| Trade Name | CAAS Workstation | |
| Common Name | Cardiovascular Angiographic Analysis System | |
| Classification: | Classification Name: Angiographic X-ray System | |
| Regulation Class: Class II | ||
| Regulation number: 21 CFR 892.1600 | ||
| Classification Product Code: IZI | ||
| Subsequent Product Code: LLZ | ||
| Predicate Devices | CAAS Workstation (K133993, Angiographic X-ray System, 21 CFR 892.1600, IZI, LLZ ) | |
| Volcano Angio-IVUS Mapping system (K060483, Echocardiograph, 21 CFR 870.2330, IYO, IZI) | ||
| Device Description | CAAS Workstation is designed as a stand-alone modular software product for | |
| viewing and quantification of X-ray angiographic images intended to run on a PC | ||
| with a Windows operating system. CAAS Workstation contains the analysis | ||
| modules QCA, QCA3D, QVA, LVA, RVA and StentEnhancer of the previously | ||
| cleared predicate device CAAS Workstation (K133993) for calculating | ||
| dimensions of coronary and peripheral vessels and the left and right ventricles, | ||
| quantification of stenosis, performing density measurements, determination of | ||
| optimal C-arm position for imaging of vessel segments and functionality to | ||
| enhance the visualization of a stent and to measure stent dimension. Semi- | ||
| automatic contour detection forms the basis for the analyses. |
Functionality to co-register X-ray angiographic images and intravascular imaging
techniques (such as intravascular ultrasound and optical coherence tomography)
is added by means of the analysis module IV-LINQ. With co-registration a
common frame of intravascular imaging techniques with X-ray angiographic
images is provided using a three-dimensional model. This functionality is based
on the Volcano Angio-IVUS Mapping system (K060483).
In the IV LINQ workflow the user has to select two angiographic X-ray images in
DICOM format. The user indicates a catheter path starting at the imaging tip.
This path can be optimized manually by adding, deleting or moving control point
on the drawn path. After the catheter path is drawn in both angiographic X-ray
images, a 3D reconstruction of the catheter path is calculated. | |
| | The user then has to select one IVUS or OCT dataset in DICOM format or the data is streamed from the intravascular imaging console with a DVI streamer. The IVUS or OCT pullback must be acquired using a motorized pullback device. After the 3D catheter path from X-ray angiographic images is calculated and the IVUS or OCT pullback is loaded, IV-LINQ co-registers each IVUS or OCT frame with a position on the 3D catheter path using a distance mapping algorithm. On intravascular images diameter and area measurements can be performed. | |
| | The quantitative results of CAAS Workstation support diagnosis and intervention of cardiovascular conditions.
The analysis results are available on screen, and can be exported in various electronic formats.
The functionality is independent of the type of vendor acquisition equipment. | |
| Intended Use | CAAS Workstation is a modular software product intended to be used by or under supervision of a cardiologist or radiologist in order to aid in reading, co-registering and interpreting cardiovascular X-Ray images to support diagnoses and for assistance during intervention of cardiovascular conditions. | |
| Indications for Use | CAAS Workstation features segmentation of cardiovascular structures, 3D reconstruction of vessel segments and catheter path based on multiple angiographic images, measurement and reporting tools to facilitate the following use:
Calculate the dimensions of cardiovascular structures; Quantify stenosis in coronary and peripheral vessels; Quantify the motion of the left and right ventricular wall; Perform density measurements; Determine C-arm position for optimal imaging of cardiovascular structures; Enhance stent visualization and measure stent dimensions; Co-registration of angiographic X-Ray images with IVUS and OCT images. CAAS Workstation is intended to be used by or under supervision of a cardiologist or radiologist. When the results provided by CAAS Workstation are used in a clinical setting to support diagnoses and for assistance during intervention of cardiovascular conditions, the results are explicitly not to be regarded as the sole, irrefutable basis for clinical decision making. | |
4
Technological Characteristics Comparison
A comparison of the technological characteristics of the predicate and subject device is given the table below.
| New Device | Predicate Device | Predicate Device | |
|---|---|---|---|
| Device name | CAAS Workstation | CAAS Workstation | Angio-IVUS Mapping System |
| Manufacturer | Pie Medical Imaging | Pie Medical Imaging | Volcano Corp. |
| 510(k) number | - | K133993 | K060483 |
| Data type | X-Ray Angiography data in DICOM format (vendor independent) IVUS data as videostream or in DICOM format (vendor independent) OCT data as DICOM format only (vendor independent) | X-Ray Angiography data in DICOM format (vendor independent) | X-Ray Angiography data in DICOM format (vendor independent) IVUS data in DICOM format |
| Import of Patient | |||
| Data | Manual through keyboard Command line interface | Manual through keyboard Command line interface | Manual through keyboard |
| Centerline | |||
| Definition | Manual and semi-automatic centerline definition based contour detection of coronary and | Manual and semi-automatic centerline definition based contour detection of coronary and | |
| New Device | Predicate Device | Predicate Device | |
| Device name | CAAS Workstation | CAAS Workstation | Angio-IVUS Mapping System |
| Manufacturer | Pie Medical Imaging | Pie Medical Imaging | Volcano Corp. |
| 510(k) number | - | K133993 | K060483 |
| peripheral vessel Manual and semi-automatic left ventricular contour definition Manual right ventricular contour definition Manual stent contour definition Contour correction and restriction Manual catheter path definition | peripheral vessel Manual and semi-automatic left ventricular contour definition Manual right ventricular contour definition Manual stent contour definition Contour correction and restriction | Manual and semi-automatic centerline / catheter path definition | |
| Image Display | 2D X-Ray image 3D reconstruction based on 2 X-Ray images 2D intravascular image Longitudinal intravascular reconstruction | 2D X-Ray image 3D reconstruction based on 2 X-Ray images | 2D X-Ray image 3D reconstruction based on 2 X-Ray images 2D intravascular image Longitudinal intravascular reconstruction |
| Image | |||
| Assessment | |||
| X-Ray | Manual and automatic calibration Basic length, diameter, density and angle measurements Vessels and ventricle dimensions (diameters, areas, volumes) Automatic and manual stenosis assessment Left and right ventricular wall motion Left ventricular myocardium dimensions Enhanced stent visualization Stent dimensions Providing a common frame of reference for IVUS and OCT data with X-ray angiographic data | Manual and automatic calibration Basic length, diameter, density and angle measurements Vessels and ventricle dimensions (diameters, areas, volumes) Automatic and manual stenosis assessment Left and right ventricular wall motion Left ventricular myocardium dimensions Enhanced stent visualization Stent dimensions | Manual and automatic calibration Basic length, diameter, density and angle measurements |
| Image | |||
| Assessment - | |||
| IVUS / OCT | Basic diameter and area measurements | Providing a common frame of reference for IVUS data with X-ray angiographic data Basic diameter and area measurements | |
| Storage of | |||
| Results | Printout Images DICOM SC XML PDF | Printout Images DICOM SC XML PDF | Printout Images DICOM SC |
| Operating | |||
| System | Windows | Windows | Windows |
5
Besides IVUS images, also OCT images can be co-registered with IV LINQ. IV LINQ bases image co-registration on the length of the intravascular imaging pullback (either IVUS or OCT). This is similar as the basis for image coregistration in the predicate device Angio-IVUS Mapping System (K060483), which uses the length of the IVUS pullback. The length of an OCT pullback is calculated using the same acquisition information as for IVUS. For IVUS DICOM and IVUS video stream data the calculation of length is also based on the same acquisition information.
The differences in technological characteristics of the subject device compared to the predicate devices therefore do not effect the safety and effectivess of the device.
Conformance Standards The device complies with the following conformance standards:
- ISO 14971:2007, Medical devices Application of risk management to . medical devices
6
| | NEMA PS 3.1 – 3.20 (2011), Digital Imaging and Communication in
Medicine (DICOM) Set. (Radiology) IEC 62304 First edition 2006-05, Medical device software – Software life
cycle processes IEC 62336:2007, Medical devices - Application of usability engineering to
medical devices |
|-------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Performance Data | System requirements – derived from the intended use and indications for use – as
well as risk control measures are verified by system testing. System testing
showed that the system requirements were implemented correctly.
For each analysis workflow a validation approach is created and the proper
functioning of the algorithms is validated.
For analysis workflows already implemented in earlier versions of CAAS
Workstation regression testing is performed to verify equivalence in numerical
results.
The validation of the distance mapping algorithm used in IV LINQ demonstrated
that the length on which co-registration is based, meets the accuracy and
reproducibility requirements.
Usability testing is performed to validate the IV-LINQ workflow of CAAS
Workstation and demonstrated that the user is able to use IV LINQ for the
purpose it was developed for.
The test results demonstrate safety and effectiveness of CAAS Workstation in
relation to its intended use and that CAAS Workstation is considered as safe and
effective as the predicate devices. |
| Substantial Equivalence | The analysis workflows QCA, QVA, LVA, RVA, QCA3D and StentEnhancer in
the previously cleared device CAAS Workstation (K133993) are available in
CAAS Workstation and are the same in terms of intended use and indications for
use and have the same technological characteristic. The difference between these
two devices is that the analysis workflow 'IV-LINQ' has been added in CAAS
Workstation. With the addition of the IV LINQ workflow, the new CAAS
Workstation is, like the predicate CAAS Workstation (K133993), intended to
support the interventional cardiologist and radiologist with diagnoses and assist
them during intervention of cardiovascular conditions. |
| | IV-LINQ has similar intended use and indications for use as the Angio-IVUS
Mapping System (K060483). Technologically similar 3D reconstruction and
distance mapping methods are used to provide co-registration in Angio-IVUS
Mapping System as are used in IV-LINQ. Besides IVUS also OCT images can be
co-registered with IV LINQ. OCT images are two-dimensional images created
using back-reflecting light versus back-reflected sound waves in IVUS imaging.
The image processing of OCT and IVUS images in IV LINQ is considered
technologically similar and as such does not affect the safety and effectiveness of
the device when used as labeled. There is no difference in the clinical use of IV
LINQ, which is providing a common frame of reference, related to the use of
OCT images versus IVUS images and the clinical use is therefore considered the
same as for the predicate Angio-IVUS Mapping System (K060483). |
| Conclusion | The testing reported in this 510(k) demonstrates that CAAS Workstation is
substantially equivalent to a combination of the predicate devices in terms of
intended use, indications for use, technological characteristics, measurements and
operating environment. As such CAAS Workstation is considered as safe and
effective as its predicate devices and performs as well as the predicate devices. |